| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/31/2013 | US20130029999 Myosin light chain kinase inhibitor compounds, compositions and related methods of use |
| 01/31/2013 | US20130029990 Pyrazole p38 map kinase inhibitors |
| 01/31/2013 | US20130029988 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 01/31/2013 | US20130029987 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith |
| 01/31/2013 | US20130029981 Compounds, compositions, and methods for controlling biofilms |
| 01/31/2013 | US20130029964 [5, 6] heterocyclic compound |
| 01/31/2013 | US20130029963 1,2,4-triazine-4-amine derivatives |
| 01/31/2013 | US20130029962 Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029944 Inhibitors of protein kinases |
| 01/31/2013 | US20130029942 Compounds and therapeutical uses thereof |
| 01/31/2013 | US20130028872 Composition and method for differentiation of human embryonic stem cells |
| 01/31/2013 | US20130028843 Kallikrein 7 modulators |
| 01/31/2013 | US20130025618 Novel cationic 4-aminoindoles, dye composition comprising a cationic 4-aminoindole, processes therefor and uses thereof |
| 01/31/2013 | CA2843251A1 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | CA2843195A1 Heterocyclyl pyrimidine analogues as jak inhibitors |
| 01/31/2013 | CA2842830A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof,and use thereof as herbicides and plant growth regulators |
| 01/31/2013 | CA2842508A1 Bis-indolic derivatives, their uses in particular as antibacterials |
| 01/30/2013 | EP2550268A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550267A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550266A2 Heterocyclic compounds useful for kinase inhibition |
| 01/30/2013 | EP2550265A1 Pyridazine compounds for controlling invertebrate pests |
| 01/30/2013 | EP2550264A1 Pyridazine compounds for controlling invertebrate pests |
| 01/30/2013 | EP2550263A2 Compositions and methods for treatment of neurodegenerative disease |
| 01/30/2013 | EP2550262A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550261A2 Pyridazine compounds for controlling invertebrate pests |
| 01/30/2013 | EP2550257A1 Pharmaceutically active disubstituted triazine derivatives |
| 01/30/2013 | EP2550254A1 Cyclopentyl - and cycloheptylpyrazoles as fxr modulators |
| 01/30/2013 | EP2549875A1 Soluble guanylate cyclase activators |
| 01/30/2013 | EP2549868A1 Chemical compounds |
| 01/30/2013 | CN102906086A Quinazoline compounds |
| 01/30/2013 | CN102906085A 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives |
| 01/30/2013 | CN102906083A Novel substituted triazole derivatives as gamma secretase modulators |
| 01/30/2013 | CN102906080A Compounds for the treatment of hepatitis C |
| 01/30/2013 | CN102898421A Pyridazinone compound containing polyethyleneglycol (PEG) modified benzyl triazolyl and preparation method and application thereof |
| 01/30/2013 | CN102898420A Synthetic route and preparation method of irbesartan |
| 01/30/2013 | CN102898419A Method for preparing voriconazole intermediate I |
| 01/30/2013 | CN102898386A Quinazoline derivative, preparation method, intermediate, composition and application |
| 01/30/2013 | CN102898378A Phthalazinone derivatives and application thereof |
| 01/30/2013 | CN102002036B Method for refining fasudil |
| 01/30/2013 | CN101316838B 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators |
| 01/29/2013 | US8362276 Reacting a vinyl sulfone compound with imide compound in presence of catalyst |
| 01/29/2013 | US8362274 Arylalkylamine compound and process for preparing the same |
| 01/29/2013 | US8362270 Self-assembled nanostructures |
| 01/29/2013 | US8362269 Preparation of 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole |
| 01/29/2013 | US8362247 Prokineticin 1 receptor antagonists |
| 01/29/2013 | US8362246 Bispyrimidines for electronic applications |
| 01/29/2013 | US8362241 Inhibitors of PI3 kinase and/or mTOR |
| 01/29/2013 | US8362235 Carboxamide compounds and methods for using the same |
| 01/29/2013 | US8362101 Multifunctional type II photoinitiators and curable compositions |
| 01/29/2013 | US8362067 3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 01/29/2013 | US8362058 Bicyclic compound, production and use thereof |
| 01/29/2013 | US8362054 Therapeutic substituted lactams |
| 01/29/2013 | US8362017 N-[5-chloro-2-(methyloxy)phenyl]-2-{[3-(1H-tetrazol-1-yl)phenyl]oxy}acetamide; antiproliferative agents; protein kinase inhibitors; drug screening |
| 01/29/2013 | US8362005 Monocyclic amide CGRP receptor antagonists |
| 01/29/2013 | US8362004 Piperazine analogs as broad-spectrum influenza antivirals |
| 01/29/2013 | US8362003 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 01/29/2013 | US8362001 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/29/2013 | US8362000 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/29/2013 | US8361994 Primary amine diazeniumdiolate heterocyclic derivatives |
| 01/29/2013 | CA2583457C Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 01/29/2013 | CA2570673C Compounds and methods for treating dyslipidemia |
| 01/29/2013 | CA2460000C Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 01/24/2013 | WO2013012995A1 Process for the synthesis of n-substituted cyclic alkylene ureas |
| 01/24/2013 | WO2013012848A1 Benzamides |
| 01/24/2013 | WO2013012844A1 Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase |
| 01/24/2013 | WO2013012298A1 9h-carbazole compounds and electroluminescent devices involving them |
| 01/24/2013 | WO2013012297A1 Novel organic electroluminescence compounds and organic electroluminescence device using the same |
| 01/24/2013 | WO2013012296A1 Novel organic electroluminescence compounds and organic electroluminescence device using the same |
| 01/24/2013 | WO2013011033A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | WO2013010382A1 Heterocyclic substituted pyrimidine compound |
| 01/24/2013 | US20130023672 PROCESS FOR PREPARING ELETRIPTAN HYDROBROMIDE HAVING a-FORM |
| 01/24/2013 | US20130023576 Pyrazole Compounds as CRTH2 Antagonists |
| 01/24/2013 | US20130023563 Amidinoaniline derivative |
| 01/24/2013 | US20130023539 Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disorders as agonists of g-protein coupled receptor 43 (gpr43) |
| 01/24/2013 | US20130023532 Indazolyl-pyrimidines as kinase inhibitors |
| 01/24/2013 | US20130023527 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 01/24/2013 | US20130023525 Gyrase inhibitors and uses thereof |
| 01/24/2013 | US20130023522 Benzamides |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023497 Triazine Derivatives and their Therapeutical Applications |
| 01/24/2013 | US20130022594 Selective fak inhibitors |
| 01/24/2013 | US20130022587 Cycloalkyl-Substituted Imidazole Derivative |
| 01/24/2013 | US20130020565 Material for organic electroluminescent element, and organic electroluminescent element using same |
| 01/24/2013 | US20130020563 Polycyclic compounds and organic electroluminescence device employing the same |
| 01/24/2013 | US20130019949 Compounds for organic thin-film solar cells and organic thin-film solar cells |
| 01/24/2013 | CA2842352A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | CA2834199A1 Benzamides |
| 01/23/2013 | EP2548874A2 Substituted piperazines as CB1 antagonists |
| 01/23/2013 | EP2548873A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 01/23/2013 | EP2548871A1 Cycloalkyl-substituted imidazole derivative |
| 01/23/2013 | EP2548869A1 Process for the Synthesis of N-substituted Cyclic Alkylene Ureas |
| 01/23/2013 | EP2548865A1 Novel bis-indolic derivatives, their uses in particular as antibacterials |
| 01/23/2013 | EP2548618A2 Organic compounds |
| 01/23/2013 | EP2547674A1 Process for the preparation of malic acid salt of sunitinib |
| 01/23/2013 | EP2547673A1 A substituted pyrimidine as a prostaglandin d2 receptor antagonist |
| 01/23/2013 | EP2547672A1 Substituted pyrimidines as prostaglandin d2 receptor antagonists |
| 01/23/2013 | EP2547662A1 Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 01/23/2013 | EP2547661A2 Indazole compounds and their uses |
| 01/23/2013 | EP2547656A1 Pyridine and pyrazine derivative for the treatment of cf |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |